Consulting & Investor Readiness
Clinical Development & Scientific Advice
Guiding Biotechs from Science to Successful Fundraising
At Astrum, we know that breakthrough science alone does not secure investment. Success depends on presenting a compelling story, supported by robust data and credible development plans.
Our Consulting & Investor Readiness services are designed to help emerging and growing life science companies prepare for the milestones that matter most, from early fundraising to strategic partnerships and licensing deals.
What We Do
Clinical Development Strategy
We design smart, milestone-driven development plans that align with both regulatory requirements and investor expectations.
Due Diligence Readiness
We support you in preparing the documentation, data packages, and operational insights that investors demand during diligence processes.
Fundraising & Partnering Support
We help you build narratives that resonate with investors, showing how your clinical roadmap de-risks development and accelerates value creation.
Operational Consulting
We advise on how to structure, prioritize, and resource your studies so that every euro spent advances both clinical and corporate objectives.
Why It Matters
Investor
Confidence
Position your program with clarity, credibility, and transparency.
Faster
Milestones
Align trial design and timelines with funding cycles to secure the next round.
Reduced
Risk
Anticipate diligence questions and avoid costly surprises.
Strategic
Advantage
Stand out in a crowded biotech landscape by pairing scientific excellence with investor readiness.
Who We Support
We work with biotech founders, clinical teams, and executive leaders who want to:
Raise Series A/B financing or extend runway with confidence.
Prepare for licensing, M&A, or strategic partnerships.
Enter new markets with a strong regulatory and commercial roadmap.
Backed by Henko Partners
Astrum is supported by Henko Partners, a private equity firm focused on high-growth European healthcare and life sciences companies. With Henko’s backing, we combine operational excellence with financial insight — helping clients not only deliver on clinical milestones but also communicate effectively with the investment community. This partnership strengthens our ability to guide biotechs through the critical intersection of science, operations, and capital strategy.
Why Astrum
As a pan-European CRO with deep clinical expertise, we bridge the gap between clinical execution and capital alignment. Our team combines regulatory know-how, operational insight, and commercial acumen to ensure your development strategy not only satisfies regulators, but also convinces investors.